vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and Professional Diversity Network, Inc. (IPDN). Click either name above to swap in a different company.

Professional Diversity Network, Inc. is the larger business by last-quarter revenue ($1.7M vs $1.1M, roughly 1.5× Insight Molecular Diagnostics Inc.). Professional Diversity Network, Inc. runs the higher net margin — -173.5% vs -2015.4%, a 1841.9% gap on every dollar of revenue. On growth, Professional Diversity Network, Inc. posted the faster year-over-year revenue change (3.1% vs -23.4%). Professional Diversity Network, Inc. produced more free cash flow last quarter ($1.4M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -1.7%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Professional Diversity Network, Inc. is a U.S.-based firm offering end-to-end diversity, equity and inclusion (DEI) solutions for corporate clients. Its services include targeted recruitment support for underrepresented talent groups, customized DEI training programs, and diversity performance data analytics, serving clients across tech, healthcare, finance and other core commercial sectors nationwide.

IMDX vs IPDN — Head-to-Head

Bigger by revenue
IPDN
IPDN
1.5× larger
IPDN
$1.7M
$1.1M
IMDX
Growing faster (revenue YoY)
IPDN
IPDN
+26.4% gap
IPDN
3.1%
-23.4%
IMDX
Higher net margin
IPDN
IPDN
1841.9% more per $
IPDN
-173.5%
-2015.4%
IMDX
More free cash flow
IPDN
IPDN
$8.4M more FCF
IPDN
$1.4M
$-7.0M
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-1.7%
IPDN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMDX
IMDX
IPDN
IPDN
Revenue
$1.1M
$1.7M
Net Profit
$-23.0M
$-2.9M
Gross Margin
42.5%
33.7%
Operating Margin
-2057.5%
-173.2%
Net Margin
-2015.4%
-173.5%
Revenue YoY
-23.4%
3.1%
Net Profit YoY
31.5%
-280.0%
EPS (diluted)
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
IPDN
IPDN
Q4 25
$1.1M
$1.7M
Q3 25
$260.0K
$1.7M
Q2 25
$518.0K
$1.6M
Q1 25
$2.1M
$1.5M
Q4 24
$1.5M
$1.6M
Q3 24
$115.0K
$1.7M
Q2 24
$104.0K
$1.7M
Q1 24
$176.0K
$1.7M
Net Profit
IMDX
IMDX
IPDN
IPDN
Q4 25
$-23.0M
$-2.9M
Q3 25
$-10.9M
$-2.4M
Q2 25
$-9.7M
$-476.0K
Q1 25
$-6.7M
$-722.1K
Q4 24
$-33.5M
$-761.9K
Q3 24
$-13.5M
$-405.0K
Q2 24
$-4.5M
$-553.1K
Q1 24
$-9.1M
$-791.8K
Gross Margin
IMDX
IMDX
IPDN
IPDN
Q4 25
42.5%
33.7%
Q3 25
53.5%
44.0%
Q2 25
67.6%
43.4%
Q1 25
62.0%
52.2%
Q4 24
40.0%
58.6%
Q3 24
43.5%
58.9%
Q2 24
48.1%
62.9%
Q1 24
25.6%
62.2%
Operating Margin
IMDX
IMDX
IPDN
IPDN
Q4 25
-2057.5%
-173.2%
Q3 25
-4249.2%
-136.3%
Q2 25
-1900.0%
-30.2%
Q1 25
-318.0%
-46.9%
Q4 24
-2262.9%
-36.8%
Q3 24
-11752.2%
-25.0%
Q2 24
-4453.8%
-34.4%
Q1 24
-5265.3%
-46.5%
Net Margin
IMDX
IMDX
IPDN
IPDN
Q4 25
-2015.4%
-173.5%
Q3 25
-4174.6%
-136.2%
Q2 25
-1880.7%
-29.0%
Q1 25
-312.0%
-48.0%
Q4 24
-2255.1%
-47.1%
Q3 24
-11733.0%
-23.9%
Q2 24
-4355.8%
-32.7%
Q1 24
-5186.9%
-45.9%
EPS (diluted)
IMDX
IMDX
IPDN
IPDN
Q4 25
$-0.75
Q3 25
$-0.34
Q2 25
$-0.30
Q1 25
$-0.26
Q4 24
$-2.19
Q3 24
$-0.98
Q2 24
$-0.36
Q1 24
$-1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
IPDN
IPDN
Cash + ST InvestmentsLiquidity on hand
$11.6M
$217.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$-31.5M
$11.7M
Total Assets
$25.8M
$17.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
IPDN
IPDN
Q4 25
$11.6M
$217.0K
Q3 25
$18.7M
$265.3K
Q2 25
$24.3M
$125.1K
Q1 25
$31.0M
$496.4K
Q4 24
$8.6M
$1.7M
Q3 24
$3.4M
$133.7K
Q2 24
$9.3M
$619.3K
Q1 24
$5.6M
$97.1K
Stockholders' Equity
IMDX
IMDX
IPDN
IPDN
Q4 25
$-31.5M
$11.7M
Q3 25
$-9.2M
$8.9M
Q2 25
$1.1M
$4.5M
Q1 25
$10.2M
$4.9M
Q4 24
$-12.3M
$5.3M
Q3 24
$9.7M
$2.1M
Q2 24
$22.7M
$2.5M
Q1 24
$11.6M
$2.3M
Total Assets
IMDX
IMDX
IPDN
IPDN
Q4 25
$25.8M
$17.9M
Q3 25
$43.9M
$12.1M
Q2 25
$50.5M
$7.3M
Q1 25
$60.4M
$7.7M
Q4 24
$35.1M
$8.0M
Q3 24
$70.2M
$5.3M
Q2 24
$74.7M
$5.8M
Q1 24
$71.0M
$5.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
IPDN
IPDN
Operating Cash FlowLast quarter
$-5.5M
$1.4M
Free Cash FlowOCF − Capex
$-7.0M
$1.4M
FCF MarginFCF / Revenue
-616.7%
84.4%
Capex IntensityCapex / Revenue
129.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
IPDN
IPDN
Q4 25
$-5.5M
$1.4M
Q3 25
$-4.5M
$-2.7M
Q2 25
$-6.3M
$-495.5K
Q1 25
$-5.9M
$-284.1K
Q4 24
$-5.4M
$-1.2M
Q3 24
$-5.5M
$-556.9K
Q2 24
$-6.0M
$-224.4K
Q1 24
$-3.8M
$-543.1K
Free Cash Flow
IMDX
IMDX
IPDN
IPDN
Q4 25
$-7.0M
$1.4M
Q3 25
$-5.6M
$-2.7M
Q2 25
$-6.6M
$-499.5K
Q1 25
$-6.2M
Q4 24
$-5.6M
$-1.2M
Q3 24
$-5.6M
$-558.9K
Q2 24
$-6.2M
$-225.9K
Q1 24
$-3.9M
$-543.6K
FCF Margin
IMDX
IMDX
IPDN
IPDN
Q4 25
-616.7%
84.4%
Q3 25
-2135.4%
-156.8%
Q2 25
-1279.5%
-30.4%
Q1 25
-288.4%
Q4 24
-374.5%
-74.0%
Q3 24
-4884.3%
-33.0%
Q2 24
-5931.7%
-13.4%
Q1 24
-2189.8%
-31.5%
Capex Intensity
IMDX
IMDX
IPDN
IPDN
Q4 25
129.9%
0.0%
Q3 25
403.8%
0.0%
Q2 25
67.4%
0.2%
Q1 25
14.4%
0.0%
Q4 24
14.4%
1.3%
Q3 24
75.7%
0.1%
Q2 24
183.7%
0.1%
Q1 24
13.6%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons